D.C. Attorney General Secures $1.2 Million from Opioid Drug Manufacturers

July 14, 2025

The District of Columbia will receive approximately $1. 2 million from eight opioid manufacturers as part of a nationwide settlement addressing their role in the opioid crisis, as announced by Attorney General Brian L. Schwalb.

Who is affected

District of Columbia residents, particularly those struggling with opioid addiction
Families of the 1,740 people who died from opioid overdoses in D.C. between 2021 and 2024
Communities throughout the United States receiving portions of the $720 million nationwide settlement
Virginia residents who will benefit from up to $16.4 million in settlement funds

What action is being taken

Eight opioid manufacturers are paying approximately $1.2 million to the District of Columbia
Seven manufacturers are being prohibited from promoting or marketing opioids and reforming their corporate practices
Indivior is being prohibited from manufacturing or selling opioid products for the next 10 years
The District's Opioid Abatement Advisory Commission is making recommendations on how to use settlement funds

Why it matters

The settlement holds corporations accountable for their role in the opioid crisis
The funds will help address harm caused by the opioid epidemic in D.C.
New restrictions on manufacturers may prevent similar issues in the future
Despite recent decreases in fatal overdoses, hundreds of D.C. residents still die annually from opioid overdoses
The settlement is part of ongoing efforts to combat the opioid crisis that has devastated communities

What's next

No explicit next steps stated in the article

Read full article from source: The Washington Informer